Alkermes' Corporate Presentation to be Webcast at the
14th Annual BIO CEO & Investor Conference
DUBLIN--(BUSINESS WIRE)--Feb. 6, 2012--
Alkermes plc (NASDAQ: ALKS) announced today that its
corporate presentation will be webcast live at the 14th
Annual BIO CEO & Investor Conference on Monday, February
13, 2012, at 2:30 p.m. EST (7:30 p.m. GMT) from the
Waldorf=Astoria Hotel in New York City. The presentation
may be accessed under the Investor tab on http://www.alkermes.com and
will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company that applies its scientific
expertise and proprietary technologies to develop
innovative medicines that improve patient outcomes. The
company has a diversified portfolio of more than 20
commercial drug products and a substantial clinical
pipeline of product candidates that address central nervous
system (CNS) disorders such as addiction, schizophrenia and
depression. Headquartered in Dublin, Ireland, Alkermes plc
has an R&D center in Waltham, Massachusetts and
manufacturing facilities in Athlone, Ireland; Gainesville,
Georgia; and Wilmington, Ohio. For more information, please
visit Alkermes' website at http://www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781-609-6823
Corporate Communications
